NHS-Galleri trial
NHS-Galleri trial
All 143,000 trial appointments took place in mobile clinics located in some of the most socioeconomically deprived locations in the UK.
participants recruited across the UK
months recruitment
retention year-on-year
participant experience good/excellent
Client testimonial
Working with EMS Healthcare over the past three years has been an extremely positive and collaborative experience. Their proactive and solution-oriented approach, coupled with their expertise in deploying community-based clinics has been invaluable. The 11 clinics they supplied and maintained have consistently met high standards, providing a safe and positive environment for participants. Their commitment to delivering exceptional service has made this partnership a great success. I have absolutely no doubt that our unprecedented level of retention through three rounds of participant appointments has been hugely dependent on the excellent experience the EMS team has provided.
Sir Harpal Kumar
President, Biopharma Business & Europe, GRAIL
Cancer screening study
NHS-Galleri early detection cancer trial
With 11 sites across the UK, participants were recruited at speed and scale from some of the most underserved postcodes in the country for the NHS-Galleri trial.
The Galleri™ blood test was developed by US Biotech GRAIL. To take part in trialling, participants were required to attend three blood draws over three years.
NHS-Galleri trial was a collaboration with the NHS, GRAIL, The Cancer Research UK and King’s College London Cancer Prevention Trials Unit.
"NHS-Galleri has set a new standard in the speed of set-up and recruitment to clinical trials. Previous trials of this magnitude would typically have taken five times as long."
Professor Peter Sasieni
Professor of Cancer Epidemiology and Director of the Cancer Research UK Cancer Prevention Trials Unit at QMUL (CPTU)
